Eli Lilly (LLY) CEO Dave Ricks said Friday that the company will make its planned GLP-1 weight-loss pill in the U.S. amid President Donald Trump’s sweeping tariffs and his push to get companies to move production inside the country’s borders.Read more... [...]
A recent CIO report revealed that enterprises are investing up to $250 million in AI despite struggling to prove ROI. Business leaders are on a quest for productivity, but with new technology integration comes the need to potentially refactor existing applications, update processes, and inspire workers to learn and adapt to the modern business environment. […]<br /> The post New Survey Fin [...]